Navigation Links
Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
Date:7/16/2009

COSTA MESA, Calif., July 16 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bullletin Board: OXBO) today announced that the company has closed on the first $5 million financing tranche with the Vatea Fund, Segregated Portfolio under a June 8, 2009 securities purchase agreement.

For additional details on the agreement, please see the Form 8-K filed with the SEC on June 8, 2009, which is available on the SEC website at www.sec.gov and through the investor relations page of the company website at www.oxybiomed.com.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis pain, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes and cosmetic applications. More information is available at www.oxybiomed.com.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
2. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
3. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
4. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
5. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
8. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
9. Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter
10. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
11. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 The ... opening of two new offices in Asia—one in Singapore ... will serve as RAPS’ Pan-Asia office , serving ... be more focused on audiences within China. , The ... its partnership with five Singapore government agencies to develop ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, ... & Data Analysis Services) & Application (Genomics, Proteomics & Drug ... Drivers, Restraints, and Opportunities in North America ... and Rest of World. Browse ... 22 Figures 364 Pages and an ...
(Date:6/18/2013)... June 18, 2013 ... announced the addition of the "Injectable ... & Nanoparticles], Devices [Disposables & Reusable, Fillable ... Injectors] & Therapeutics [Diabetes & Oncology] - ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ...
Breaking Biology Technology:RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... and will be integrated into ... the deCODEme(TM) service, REYKJAVIK, ... problem that contributes to millions of,deaths around the world each year. ... known about why some people are,particularly likely to get addicted to ...
... Sciences Corporation announced,today the launch of the ... ). During the past two years, IC ... launched membership program,such as scientific tools, industry ... instruments for professional, consumer, and,therapeutics medical market ...
... 2, 2008 PAREXEL International,Corporation (Nasdaq: ... today announced that Larry Ereshefsky, Pharm.D., F.C.C.P.,B.C.C.P., ... as Vice Presidents,of Clinical Pharmacology Consulting Services ... leading experts advise clients on,early phase clinical ...
Cached Biology Technology:A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 2A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 3A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 4IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare 2PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 2PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 3PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 4PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 5
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... and a major cause is a deadly fungus thought ... shows they can also die from this pathogen, contrary ... that just spreads the disease. , When researchers raised ... found at least one strain of this pathogen, ... fungus, can be fatal to year-old juveniles. However, bullfrogs ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2HIV prevention among female sex workers in India reduces HIV and syphilis 2
... proteins has been found to constitute one of the ... have discovered. The engineers and biologists from Duke University ... could lead to a new understanding of mechanical processes ... potent nanoscale "shock absorbers" or "gate-opening springs" in tiny ...
... Rutgers researchers have found that the curry spice ... prevention of prostate cancer, particularly when combined with ... known as curcumin, along with phenethyl isothiocyanate (PEITC), ... group of vegetables that includes watercress, cabbage, winter ...
... an uncanny ability to skim through text, instantly recognizing ... 6000 years ago--long after humans evolved. Thus, neuroscientists ... called the Visual Word Form Area (VWFA) is truly ... Functional MRI scans have shown that the area specifically ...
Cached Biology News:Protein 'nanosprings' most resilient found in nature 2Protein 'nanosprings' most resilient found in nature 3Protein 'nanosprings' most resilient found in nature 4Curry and cauliflower could halt prostate cancer 2'Word-vision' brain area confirmed 2
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Request Info...
Request Info...
Biology Products: